Recombinant interleukin-2 and recombinant interferon alpha immunotherapy cardiovascular toxicity.
Schechter
D
D
Nagler
A
A
D004338:Drug Combinations; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006331:Heart Diseases / Q000139:chemically induced; D006352:Heart Ventricles; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000009:adverse effects*; D007376:Interleukin-2 / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced; D011994:Recombinant Proteins
D004338:Drug Combinations; D016898:Interferon-alpha; D007376:Interleukin-2; D011994:Recombinant Proteins